Welcome to our dedicated page for Innovate news (Ticker: VATE), a resource for investors and traders seeking the latest updates and insights on Innovate stock.
INNOVATE Corp. reports developments across a diversified portfolio organized around Infrastructure, Life Sciences and Spectrum. News commonly covers consolidated earnings, subsidiary performance, DBM Global cash dividends, steel construction activity, Spectrum network and broadcasting updates, and capital or operating developments within portfolio companies.
Life Sciences updates center on MediBeacon, an equity method investment developing fluorescent tracer agents and transdermal detection for kidney function assessment through the TGFR System, including FDA, NMPA and CE Mark regulatory milestones. INNOVATE also reports R2 system sales and commercial agreements as part of its portfolio-company operating updates.
INNOVATE (NYSE: VATE) agreed to sell its approximately 91.21% stake in DBM Global (DBMG) to IES Holdings (Nasdaq: IESC), as part of a 100% acquisition of DBMG valued at an aggregate base purchase price of $650 million, subject to customary adjustments.
According to INNOVATE, consideration to INNOVATE and DBM Global Intermediate Holdco will include their pro rata share of $510 million cash (approximately $453 million after giving effect to their receipt of all IES stock), plus 215,487 IES shares valued at $140 million at signing, and an additional $35 million cash at closing related to a joint tax election. Other DBMG stockholders holding about 8.79% will receive all-cash consideration. INNOVATE intends to use all net proceeds to reduce outstanding debt. The transaction has board approval and is expected to close in the quarter ending December 31, 2026, subject to regulatory and other customary closing conditions.
IES Holdings (NASDAQ: IESC) has entered into a definitive agreement to acquire DBM Global, a vertically integrated structural steel fabrication, erection and industrial services platform, from INNOVATE Corp (NYSE: VATE). The consideration for DBM Global, including minority interests, is approximately $650 million, payable in cash and shares of IES common stock.
DBM Global generated about $1.3 billion in revenue in the twelve months ended March 31, 2026, employs roughly 3,400 people and operates over 2 million square feet of facilities across the U.S. Upon closing, expected in the quarter ending December 31, 2026 subject to customary conditions and regulatory approvals, DBM Global will form a new Structural line of business within IES, expanding its capabilities across commercial, industrial, data center, stadium and infrastructure markets.
INNOVATE Corp. (NYSE: VATE) reported second quarter 2026 consolidated revenue of $421.6 million, up 74.2% year over year, driven mainly by Infrastructure subsidiary DBM Global (DBMG). Net income attributable to common and participating preferred stockholders was $10.4 million, versus a loss of $22.0 million, and diluted EPS was $0.71, compared with a loss of $1.67. Total Adjusted EBITDA rose to $46.3 million from $15.7 million.
DBMG generated revenue of $414.0 million (up 77.6%), net income of $26.4 million and Adjusted EBITDA of $48.7 million, with Adjusted EBITDA margin of 11.8% and record adjusted backlog of $2.7 billion. Life Sciences revenue was $2.2 million (down from $3.2 million), while Spectrum (Broadcasting) revenue was $5.4 million (slightly below $5.7 million) but segment net income improved to $8.4 million from a $6.1 million loss.
Broadcasting closed a $105 million refinancing and INNOVATE agreed to sell a controlling interest in Broadcasting to CONX CORP., after which CONX is expected to own ~75% and INNOVATE ~25%. INNOVATE is also pursuing substantial asset dispositions, including a sales process for DBMG and a majority interest in Broadcasting, alongside broader debt and liability changes.
INNOVATE Corp. (NYSE: VATE) will release its second quarter 2026 financial results on Thursday, August 6, 2026, after market close. On the same day, the company will host an earnings conference call at 4:30 p.m. ET to review results, operations and strategy.
The live call can be accessed via domestic dial-in 1-877-704-4453 or international 1-201-389-0920, and will also be webcast through the Investor Relations section of INNOVATE’s website. A replay will be available by phone and online, with telephone replay access through August 20, 2026 using conference number 13761666.
INNOVATE (NYSE:VATE) announced that its operating subsidiary DBM Global will pay a cash dividend of about $12 million, or $3.12 per share, on August 3, 2026 to DBMG stockholders of record on July 20, 2026. INNOVATE, as the largest DBMG stockholder, expects to receive about $11 million. INNOVATE’s public stockholders will not receive this dividend.
INNOVATE (NYSE: VATE) announced a refinancing for HC2 Broadcasting and a definitive agreement to sell a controlling stake in Broadcasting to CONX CORP, subject to regulatory approvals.
CONX is expected to own about 75% of Broadcasting post-closing, with INNOVATE retaining about 25%, plus options and an equity commitment structure totaling up to $180 million.
INNOVATE Corp (NYSE: VATE) reported first quarter 2026 revenue of $364.8 million, up 33% year over year, driven mainly by Infrastructure. Net loss attributable to common and participating preferred stockholders improved to $17.2 million from $24.8 million, while Total Adjusted EBITDA rose to $19.7 million from $7.2 million.
Infrastructure revenue grew 35.1% to $357.9 million with net income of $9.3 million. Life Sciences saw MediBeacon secure a CE mark in Europe, and R2 expanded internationally. Spectrum revenue declined to $5.3 million amid advertising softness. Cash and equivalents increased to $134.6 million.
INNOVATE Corp. (NYSE: VATE) will report first quarter 2026 financial results on May 14, 2026 after market close and will host an earnings conference call the same day at 4:30 p.m. ET.
The call will be broadcast live on INNOVATE’s Investor Relations website and a replay will be available approximately three hours after the call through May 28, 2026. Dial-in and replay numbers are provided for domestic and international attendees.
INNOVATE (NYSE: VATE) said DBM Global Inc., its operating subsidiary, will pay a $3.0 million cash dividend (about $0.78 per share) on April 28, 2026 to stockholders of record as of April 13, 2026.
INNOVATE, as DBMG’s largest stockholder, expects to receive ~$2.7 million; INNOVATE individual stockholders are not eligible for the payout.
INNOVATE (NYSE: VATE) said MediBeacon, an equity-method investment, received EU CE Mark under MDR for its TGFR Monitor and TGFR Reusable Sensor (both Class IIa).
The certified devices join the CE marked TGFR Disposable Ring and Lumitrace injection (approved in U.S. and China; EU submission pending) to form the TGFR System for transdermal GFR assessment, enabling potential inclusion in European clinical trials later in 2026.